Efficacy analysis of MASTERKEY-265 phase 1b study of talimogene laherparepvec (T-VEC) and pembrolizumab (pembro) for unresectable stage IIIB-IV melanoma. Conference Paper uri icon

authors

  • Long, Georgina V
  • Dummer, Reinhard
  • Ribas, Antoni
  • Puzanov, Igor
  • VanderWalde, Ari
  • Andtbacka, Robert Hans Ingemar
  • Michielin, Olivier
  • Olszanski, Anthony J
  • Malvehy, Josep
  • Cebon, Jonathan S
  • Fernandez, Eugenio
  • Kirkwood, John M
  • Gajewski, Thomas
  • Gause, Christine K
  • Chen, Lisa
  • Gorski, Kevin
  • Anderson, Abraham
  • Kaufman, David Ross
  • Chou, Jeffrey
  • Hodi, F Stephen

publication date

  • May 20, 2016